Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
- Engineering physical biomaterial properties to manipulate macrophages phenotype: From bench to bedside
- Early factors in the immune response to biomaterials
- Nanotechnology and biomaterials for immune modulation and monitoring
- Immune-instructive materials and surfaces for medical applications
- Electrospun tissue regeneration biomaterials and immunomodulation
- Biomaterials and immunomodulation for spinal cord repair
- Biomaterial strategies to treat autoimmunity and unwanted immune responses to anti-drug antibodies and transplanted tissues
- Lipids as regulators of inflammation and tissue regeneration
- Biomaterials modulation of the tumor immune environment for cancer immunotherapy
- Circumventing immune rejection and foreign body response to therapeutics of type 1 diabetes
- Machine learning and mechanistic computational modeling of inflammation as tools for designing immunomodulatory biomaterials
Biomaterials have existed for millennia as mechanical replacement structures following disease or injury. Biomaterial design has changed markedly from structural support with an “inert” immune profile as the primary objective to designs that elicit an integrative local tissue response and a pro-repair immune cell phenotype.
Immunomodulatory Biomaterials: Regulating the Immune Response with Biomaterials to Affect Clinical Outcome offers a single, comprehensive reference on biomaterials for modulation of the host response, for materials scientists, tissue engineers and those working in regenerative medicine. This book details methods, materials and strategies designed to regulate the host immune response following surgical implantation and thus facilitate specific local cell infiltration and tissue deposition.
There has been a dramatic transformation in our understanding of the role of the immune system, both innate and adaptive; these changes include recognition of the plasticity of immune cells, especially macrophages, cross-talk between the immune system and stem cells, and the necessity for in situ transition between inflammatory and regulatory immune cell phenotypes. The exploitation of these findings and the design and manufacture of new biomaterials is occurring at an astounding pace. There is currently no book directed at the interdisciplinary principles guiding the design, manufacture, testing, and clinical translation of biomaterials that proactively regulate the host tissue immune response.
The challenge for academia, industry, and regulatory agencies to encourage innovation while assuring safety and maximizing efficacy has never been greater. Given the highly interdisciplinary requirements for the design, manufacture and use of immunomodulatory biomaterials, this book will prove a useful single resource across disciplines.
- Holistically covers the design, manufacture, testing, and clinical translation of biomaterials that proactively regulate the host tissue immune response
- Provides a single reference for understanding and utilizing the host response in biomaterials design
- An international collaboration of leading researchers in the field offering a novel insight into this fast-growing area
Academic and industrial researchers as well as postgraduate students of materials science and regenerative medicine. Biomedical engineers
- No. of pages:
- © Woodhead Publishing 2021
- 5th August 2021
- Woodhead Publishing
- Paperback ISBN:
Dr. Badylak is Professor in the Departments of Surgery and BioEngineering at the University of Pittsburgh and Deputy Director of the McGowan Institute for Regenerative Medicine, Pittsburgh, PA, USA. The focus of Dr. Badylak's work has been the mechanisms by which extracellular matrix signals host tissues to promote and support functional tissue reconstruction.
Professor in the Departments of Surgery and BioEngineering, University of Pittsburgh; Deputy Director of McGowan Institute for Regenerative Medicine, Pittsburgh, PA, USA
Dr. Elisseeff began her career at Carnegie Mellon University and Harvard-MIT. After this, she was a Fellow at the National Institute of General Medical Sciences Pharmacology Research Associate Program, and later became an assistant professor in the Department of Biomedical Engineering at Johns Hopkins University. In 2004, Elisseeff cofounded Cartilix, Inc., a startup that translated adhesive and biomaterial technologies for treating orthopedic disease, acquired by Biomet Inc in 2009.In 2009, she also founded Aegeria Soft Tissue and Tissue Repair, new startups focused on soft tissue regeneration and wound healing. Dr. Elisseeff serves on the Scientific Advisory Boards of Bausch and Lomb, Kythera Biopharmaceutical, and Cellular Bioengineering Inc. She has received the Carnegie Mellon Young Alumni Award, Arthritis Investigator Award from the Arthritis Foundation, Yasuda Award from the Society of Physical Regulation in Medicine and Biology and was named by Technology Review magazine as a top innovator under 35 in 2002 and top 10 technologies to change the future. In 2008, Dr. Elisseeff was elected a fellow in the American Institute for Medical and Biological Engineering and a Young Global Leader in the World Economic Forum. She has published over 120 articles, book chapters and patent applications and given over 130 national and international invited lectures.
Morton Goldberg Professor, Wilmer Eye Institute and Biomedical Engineering, John Hopkins Medicine, Baltimore, MD, USA
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.